You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Clinical characteristics

From: Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma

Variables n (%)
Gender   
  Male 80 77.7
  Female 23 22.3
Age (year)   
  Median 59  
  Range 21-80  
ECOG   
  0 38 36.9
  1 65 63.1
Hepatitis   
  None 2 1.9
  HBV 73 70.9
  HCV 9 8.7
  NBNC 9 8.7
  Alcoholic 10 9.7
Liver cirrhosis   
  No 32 31.1
  Yes 71 68.9
PVTT   
  No 45 43.7
  Yes 58 56.3
AFP (IU/mL)   
  ≤ 400 67 65.0
  > 400 36 35.0
Child-Pugh class before radiotherapy   
  A 91 88.3
  B 12 11.7
AJCC stage   
  II 14 13.6
  III 81 78.6
  IVA 8 7.8
Previous treatment   
  None 7 6.8
  TACE 95 92.2
  RFA 8 7.8
  PEI 8 7.8
  Chemotherapy 14 13.6
  1. Abbreviations: ECOG PS Eastern Cooperative Oncology Group performance status, HBV hepatitis B virus, HCV hepatitis C virus, NBNC non-B, non-C, PVTT portal vein tumor thrombosis, AFP alpha-fetoprotein, AJCC American Joint Committee on Cancer, TACE transcarterial chemoembolization, RFA radiofrequency ablation, PEI percutaneous ethanol injection.